BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...

And regular polling carried out by YouGov suggests adults are increasingly likely to say that vaccines have harmful side ...

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...

and AbbVie stock (up 15%), Johnson & Johnson’s stock performance has been muted. This is attributed to declining Covid-19 vaccine sales, falling Remicade revenue, and increased competition for ...

University of Idaho researchers found that the COVID-19 vaccine does not have any adverse effects on a mother’s breast milk.

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 ... That includes slowing COVID-19 vaccine sales — a theme ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks. Wall Street ended the first trading day of the week on a mixed note, with the ...

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

So far, Health Canada has approved the Moderna Spikevax, Pfizer-BioNTech Cominarty, AstraZeneca Vaxevria and Janssen (Johnson & Johnson) vaccines for use in Canada. More on Canada More videos CRA ...

Then there were safety concerns. The AstraZeneca and Johnson & Johnson vaccines were linked to a rare, but serious, blood clot in the brain and their use was restricted to certain groups.